Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 306

Results For "INST"

3119 News Found

NATCO signs licensing agreement with Lilly for Baricitinib
News | May 18, 2021

NATCO signs licensing agreement with Lilly for Baricitinib

Natco has withdrawn its application filed with the Indian Patent Office, seeking Compulsory License against Lilly for Baricitinib for Covid-19 in India


Sun Pharma Advanced Research Q4FY21 loss at Rs. 56.72 Cr
News | May 18, 2021

Sun Pharma Advanced Research Q4FY21 loss at Rs. 56.72 Cr

The company has posted net loss of Rs. 99.54 crores for the period ended March 31, 2020


Aarti Drugs Q4FY21 consolidated net profit drops to Rs. 51.65 Cr
News | May 16, 2021

Aarti Drugs Q4FY21 consolidated net profit drops to Rs. 51.65 Cr

Aarti Drugs has reported total income of Rs.2159.30 crores during the 12 months period ended March 31, 2021


Dr. Reddy's Sputnik V India price is Rs. 995.40
News | May 15, 2021

Dr. Reddy's Sputnik V India price is Rs. 995.40

The company is working closely with its six manufacturing partners in India


Dr. Reddy's Laboratories see marginal dip in FY 2021 PAT
News | May 15, 2021

Dr. Reddy's Laboratories see marginal dip in FY 2021 PAT

Dr. Reddy's Laboratories has reported total income of Rs.19338.9 crores during FY ended March 31, 2021


Cipla reports Q4FY21 consolidated net profit of Rs. 413.38 Cr
News | May 15, 2021

Cipla reports Q4FY21 consolidated net profit of Rs. 413.38 Cr

The company has reported total income of Rs.19425.58 crores during FY ended March 31, 2021


Gap between two doses of Covishield extended; No extension for Covaxin
News | May 14, 2021

Gap between two doses of Covishield extended; No extension for Covaxin

The COVID Working Group has recommended extension of the gap between the first and second doses of Covishield


Govt. to allow 100% doses of imported and ready to use foreign vaccine
News | May 14, 2021

Govt. to allow 100% doses of imported and ready to use foreign vaccine

Proactively engaging with foreign vaccine manufacturers like Moderna, Pfizer etc., to apply for Emergency Use Authorization in India so that these vaccines can be easily imported and made available in India


Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr
News | May 13, 2021

Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr

Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021


Lupin reports Q4FY21 consolidated PAT of Rs. 460.36 Cr
News | May 13, 2021

Lupin reports Q4FY21 consolidated PAT of Rs. 460.36 Cr

It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021